Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925

BACKGROUND: The major limitation to the success of chemotherapy in osteosarcoma is the development of multidrug resistance (MDR). Preventing the emergence of MDR during chemotherapy treatment has been a high priority of clinical and investigational oncology, but it remains an elusive goal. The NSC23...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, X, Yang, P, Shen, J, Osaka, E, Choy, E, Cote, G, Harmon, D, Zhang, Z, Mankin, H, Hornicek, F J, Duan, Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056062/
https://www.ncbi.nlm.nih.gov/pubmed/24853187
http://dx.doi.org/10.1038/bjc.2014.254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056062/
https://www.ncbi.nlm.nih.gov/pubmed/24853187
http://dx.doi.org/10.1038/bjc.2014.254

Ejemplares similares